Screener
Aurinia Pharmaceuticals AUPH Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
FAQ
- What is Aurinia Pharmaceuticals's total assets?
- Aurinia Pharmaceuticals (AUPH) reported total assets of $792.26M in Q2 2026.
- How has Aurinia Pharmaceuticals's total assets changed year-over-year?
- Aurinia Pharmaceuticals's total assets increased by 57.6% year-over-year, from $502.56M to $792.26M.
- What is the long-term trend for Aurinia Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total assets has grown at a 10.1% compound annual growth rate (CAGR), from $463.66M to $751.59M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Aurinia Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude